PHCentral RSS - rss FIRE feed Sat, 28 May 2016 09:05:16 GMT Mast Therapeutics Announces Positive Interim Results from Phase 2 Trial in Select PH Patients May 29, 2016 Benefits of Anticoagulant Use in PAH Largely Unknown and in Need of Study, ResearchersSay May 28, 2016 Breakthrough could help sufferers of fatal lung disease May 27, 2016 The Reviva Pharmaceuticals results were presented at the American Thoracic Society International Conference 2016 May 26, 2016 PAH Drug, Riociguat, Found Not to Alter the Effectiveness of Oral Contraceptives May 25, 2016 Speaker: Treatment of systemic lupus erythematosus should be flexible{6c7e8294-e434-4e57-a45a-c84ab21bb5d3}/speaker-treatment-of-systemic-lupus-erythematosus-should-be-flexible May 25, 2016 Mast Therapeutics (MSTX) Reports Positive Interim Results From Second Phase 2a Study of AIR001 in Patients With HFpEF May 24, 2016 MEF2C-MYOCD and Leiomodin1 Suppression by miRNA-214 Promotes Smooth Muscle Cell Phenotype Switching in PAH May 23, 2016 Vascular BioSciences Presents New Data from Pulmonary Hypertension Studies at ATS 2016 May 21, 2016 Safety, efficacy, and clinical utility of macitentan in the treatment of pulmonary arterial hypertension May 20, 2016 Actelion gets EU go-ahead for Uptravi in PAH May 19, 2016 US trial tests machine that 'reconditions' lungs outside body May 18, 2016 Bayer Stops Phase II Adempas Study Due to Safety Issues May 17, 2016 ]]> PDE4 Inhibitor Identified in Study as New and Promising Treatment for Pulmonary Hypertension May 16, 2016 More evidence for combination therapy benefits in PAH May 15, 2016 CHEST, shows benefits for a range of individual clinical indicators, including 6-minute walk distance, functional class and haemodynamics.]]> Detailed digital human models could hold key to future clinical research May 14, 2016 Long-term improvement during tadalafil therapy in a patient with pulmonary hypertension secondary to pulmonary Langerhans cell histiocytosis May 13, 2016 HIPPO-integrin Linked Kinase Crosstalk Controls Self-sustaining Proliferation and Survival in Pulmonary Hypertension May 12, 2016 ]]> Chronic thromboembolic pulmonary hypertension - a diagnostic and therapeutic update. May 11, 2016 AVEO Announces Filing of Provisional Patent Applications for AV-353, a Notch 3-Specific Inhibitor Antibody for PAH May 10, 2016 Older Lung Donors Raise Mortality Risk Only Slightly May 9, 2016 Cumberland Pharmaceuticals Announces New Program To Develop Vasculan™ For Systemic Sclerosis™+For+Systemic+Sclerosis/11546025.html May 8, 2016 Effect of dual pulmonary vasodilator therapy in pulmonary arterial hypertension associated with congenital heart disease May 7, 2016 Aerosol-Delivered Gene Therapy Seen to Stop Vascular Remodeling in PH Study in Pigs May 6, 2016 Right Ventricle Enlargement Successfully Treated in PAH Animal Model Using Ranolazine, a Heart Drug May 5, 2016 Right Ventricle Dysfunction in PAH May Be Treated by Drug Targeting a Signaling Pathway Independent of Arterial Pressure May 4, 2016 Tissue-engineered artificial lung that mimics the response of the human lung to drugs, toxins and other agents May 4, 2016 Pediatric research: Researchers now think fibrosis can be reversed May 3, 2016 PAH Is Rising in Elderly, and So Are Challenges in Correctly Diagnosing and Treating Their Disease May 3, 2016 ]]> Special training strengthens heart of patients with pulmonary hypertension: study May 2, 2016 Scientists Discover Shared Genes in COPD and IPF, Pointing to Potential Drug Development May 2, 2016 Yoga Shows Promise as Way to Improve Quality of Life in Pulmonary Arterial Hypertension (PAH) Patients May 1, 2016 ]]> Drugs for Pulmonary Arterial Hypertension: Comparative Efficacy, Safety, and Cost-Effectiveness May 1, 2016 Gene therapy halts pulmonary hypertension progression in large animal pre-clinical study April 30, 2016 TGA approves combination treatment for PAH treatment April 30, 2016 Memorial Hermann Heart & Vascular Institute-Texas Medical Center Launches Lung Transplant Program April 29, 2016